title: Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease.
abstract: Glucosamine and chondroitin sulfate are molecules involved in the formation of articular cartilage and are frequently used for symptom relief in patients with arthrosis. These molecules are well tolerated with scarce secondary effects. Very few cases of possible hepatotoxicity due to these substances have been described. The aim of this paper is to report the frequency of presumed glucosamine hepatotoxicity in patients with liver disease. A questionnaire was given to 151 consecutive patients with chronic liver disease of different etiology (mean age 59 years, 56.9% women) attended in an outpatient clinic with the aim of evaluating the frequency of consumption of these drugs and determine whether their use coincided with a worsening in liver function test results. Twenty-three patients (15.2%) recognized having taken products containing glucosamine or chondroitin sulfate previously or at the time of the questionnaire. Review of the clinical records and liver function tests identified 2 patients presenting an elevation in aminotransferase values temporarily associated with glucosamine treatment; one of the cases simultaneously presented a skin rash attributed to the drug. Review of these two patients and the cases described in the literature suggest toxicity of glucosamine and chondroitin sulfate. The clinical spectrum is variable, and the mechanism of toxicity is not clear but may involve reactions of hypersensitivity. The consumption of products containing glucosamine and/or chondroitin sulfate is frequent among patients with chronic liver diseases and should be taken into account on the appearance of alterations in liver function tests not explained by the underlying disease.
authors: Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clínic, 08036 Barcelona, Spain.
authors: Cristian
authors: C
authors: Cerda
authors: Miguel
authors: M
authors: Bruguera
authors: Albert
authors: A
authors: Parés
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D002809:Chondroitin Sulfates / Q000009:adverse effects*; D019587:Dietary Supplements / Q000009:adverse effects*; D005260:Female; D005944:Glucosamine / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D002809:Chondroitin Sulfates; D005944:Glucosamine
keywords: Chondroitin sulphate; Glucosamine; Hepatotoxicity; Osteoarthritis; Toxic hepatitis
references: BMJ. 2010 Sep 16;341:c4675
references: 20847017
references: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002946
references: 15846645
references: BMJ Case Rep. 2009;2009:
references: 21887162
references: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):51-6
references: 16170388
references: Gastroenterol Clin Biol. 2007 Apr;31(4):449-50
references: 17483788
references: J Knee Surg. 2004 Oct;17(4):185-93
references: 15553585
references: Pharmacotherapy. 2010 Jul;30(7):750, 258e-262e
references: 20586134
references: Arthritis Rheum. 2008 Oct;58(10):3183-91
references: 18821708
references: Ann Pharmacother. 1998 May;32(5):574-9
references: 9606479
references: Int J Rheum Dis. 2011 May;14(2):152-8
references: 21518314
references: J Int Med Res. 2008 Nov-Dec;36(6):1161-79
references: 19094424
references: J Orthop Surg (Hong Kong). 2009 Apr;17(1):72-6
references: 19398798